Panacea Life Sciences Holdings, Inc. Stock
Stocks
PLSH
US69810P1093
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
22:51:42 02/06/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0350 USD | -.--% |
|
-65.00% | -30.00% |
| 11-18 | Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH | CI |
| 06/05/24 | Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Market Cap | 519K 453K 427K 388K 727K 49.8M 730K 5.12M 1.98M 25.32M 1.95M 1.91M 81.47M | P/E 2022 |
-0.11x | P/E 2023 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 22.05M 19.23M 18.15M 16.49M 30.89M 2.12B 31.02M 217M 83.92M 1.08B 82.83M 80.99M 3.46B | EV / Sales 2022 |
11.6x | EV / Sales 2023 | 10.1x |
| Free-Float |
18.65% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 week | -65.00% | ||
| Current month | -65.00% | ||
| 1 month | -57.57% | ||
| 6 months | -26.78% | ||
| Current year | -30.00% |
| 1 week | 0.04 |  | 0.09 |
| 1 month | 0.04 | | 0.1 |
| Current year | 0.02 | | 0.14 |
| 1 year | 0.02 | | 0.2 |
| 3 years | 0.02 | | 0.35 |
| 5 years | 0.02 | | 3.33 |
| 10 years | 0.02 | | 5.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
Leslie Buttorff
CEO | Chief Executive Officer | 69 | 30/06/2021 |
Nick Cavarra
PSD | President | - | - |
| Chief Tech/Sci/R&D Officer | 61 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Leslie Buttorff
CHM | Chairman | 69 | 30/06/2021 |
Lawrence Wert
BRD | Director/Board Member | 68 | 29/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/18/23 A | Buy | Chief Executive Officer | 20,000 | 0.1133% | ||
| 6/2/23 A | Free | Chief Executive Officer | 763,000 | 4.9209% | ||
| 5/19/23 A | Other | Chief Executive Officer | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -65.00% | -46.15% | -85.20% | 4.31M | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,028B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 466B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 208B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 186B | |
| Average | +0.18% | +2.93% | +18.92% | +32.25% | 360.17B | |
| Weighted average by Cap. | +0.23% | +3.09% | +35.15% | +61.76% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.63M 1.42M 1.34M 1.22M 2.28M 156M 2.29M 16.05M 6.19M 79.37M 6.11M 5.98M 255M | 2.38M 2.08M 1.96M 1.78M 3.34M 229M 3.35M 23.52M 9.08M 116M 8.96M 8.76M 374M |
| Net income | -9.14M -7.97M -7.53M -6.84M -12.81M -877M -12.86M -90.17M -34.8M -446M -34.34M -33.58M -1.44B | -8.02M -6.99M -6.6M -5.99M -11.23M -769M -11.28M -79.05M -30.51M -391M -30.11M -29.44M -1.26B |
| Net Debt | 17.85M 15.57M 14.7M 13.35M 25.01M 1.71B 25.11M 176M 67.95M 871M 67.07M 65.58M 2.8B | 21.53M 18.77M 17.73M 16.1M 30.16M 2.07B 30.29M 212M 81.94M 1.05B 80.88M 79.08M 3.38B |
Employees
40
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/09/26 | $0.0725 | -14.71% | 17,700 |
| 16/09/26 | $0.0850 | -7.93% | 92,950 |
| 15/09/26 | $0.0923 | -7.68% | 100 |
- Stock Market
- Stocks
- PLSH Stock
Select your edition
All financial news and data tailored to specific country editions
